K. Vermeylen

Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the european organization for research and treatment of cancer–-genitourinary group study 30853

D.W.W. Newling, L. Denis, K. Vermeylen · Cancer · 1993 · 83 citations

Surgical Oncology, Cancer–-genitourinary Group, Cancer Management +17

Zoladex and Flutamide Versus Bilateral Orchiectomy

F. Keuppens, L. Denis, Philip Smith et al. · Cancer · 1990 · 42 citations · Full text

Total Androgen Ablation: European Experience

L. Denis, Philip Smith, Jandeilson L. Moura et al. · Urologic Clinics of North America · 1991 · 33 citations

Total Androgen Ablation, Andrology, Urology +4

Vinblastine in metastatic renal cell carcinoma: EORTC phase II Trial 30882

Sophie D. Fosså, J.P. Droz, M. Pavone‐Macaluso et al. · European Journal of Cancer · 1992 · 32 citations

Tumor Biology, Urology, Genitourinary Cancer +5

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

R. de Wit, Richard Sylvester, C Tsitsa et al. · British Journal of Cancer · 1997 · 30 citations · Full text

Marker Half-life, Urology, Marker Concentration +8